Development of point-of-care product for alzheimer's disease
Alzheimer’s disease (AD) is a neurodegenerative disease affecting over 55 million people worldwide, with approximately 60% undiagnosed cases. Early detection is critical in allowing early intervention that may significantly impact patients’ quality of life and reduce overall AD-related cost. Current...
| Main Author: | |
|---|---|
| Other Authors: | |
| Format: | Final Year Project (FYP) |
| Language: | English |
| Published: |
Nanyang Technological University
2022
|
| Subjects: | |
| Online Access: | https://hdl.handle.net/10356/163584 |